AskBio CEO and Co-Founder Sheila Mikhail receives 2022 Entrepreneurial Award from University of Chicago Booth School of Business

Prestigious recognition for excellent skilled achievement in the development of a prosperous company awarded to Booth Faculty of Company Alumni

Investigate TRIANGLE PARK, N.C., June 3, 2022 /PRNewswire/ — Asklepios BioPharmaceutical, Inc. (AskBio), an independently operated subsidiary of Bayer AG, right now declared that CEO and Co-Founder Sheila Mikhail was identified by the College of Chicago Booth University of Enterprise for excellent qualified achievement amid its alumni. As a 1993 finance MBA graduate with honors, Ms. Mikhail has been recognized with the 2022 Entrepreneurial Award.

“This award is tremendously meaningful as the Booth School of Enterprise is one particular of the nation’s prime ranked business colleges,” explained AskBio Co-Founder and CEO Sheila Mikhail. “The award is a reflection of the achievements that could not be probable without having the guidance of a earth-class team at AskBio as we proceed to advance our study, clinical candidates and manufacturing abilities.”

Ms. Mikhail acquired a JD with honors from Northwestern University, a finance MBA with honors from the College of Chicago, and a BS with optimum honors from the College of Illinois at Urbana-Champaign. She co-established AskBio in 2001 with Dr. R. Jude Samulski, who is viewed as one particular of the main pioneers for AAV gene therapy know-how.  Because co-founding AskBio, and less than the management of Ms. Mikhail, the enterprise, like its manufacturing facilities, has developed to utilize in excess of 700 biotech industry experts working in 5 countries.

Eighteen months just after closing a collection A funding round of $235 million in April 2019, Ms. Mikhail orchestrated a $4 billion acquisition by Bayer AG in October 2020.  Beneath Ms. Mikhail’s leadership, AskBio is flourishing with an expansive gene remedy know-how toolbox, 3 state-of-the-artwork producing amenities in San Sebastian Spain and a strong therapeutic pipeline, all at different medical phases, to handle Pompe Disease, Limbe Girdle Muscular Dystrophy, Numerous Technique Atrophy, Congestive Heart Failure, Huntington’s Condition, and Parkinson’s Sickness.

“In my check out, Sheila is a single of the most attained Biotech executives in the market,” commented Dr. Samulski, AskBio’s Co-Founder and Main Scientific Officer. “The recognition by University of Chicago Booth University of Business enterprise is a testament of her unparalleled organization acumen blended with her significant command of genetic science”

The Distinguished Alumni awards are only obtainable to graduates of Chicago Booth. The Entrepreneurial Award is provided to a man or woman who has demonstrated qualified achievement of the greatest caliber in the management and development of a productive company and is recognition by colleagues and friends for exceptional leadership and administrative capabilities.

About AskBio

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG obtained in 2020, is a entirely integrated gene remedy firm focused to creating lifestyle-conserving medicines that get rid of genetic disorders. The enterprise maintains a portfolio of scientific systems across a array of neuromuscular, central nervous system, cardiovascular and metabolic disorder indications with a medical-stage pipeline that involves therapeutics for Pompe disorder, Parkinson’s sickness, and congestive heart failure. AskBio’s gene remedy system includes Pro10™, an business-primary proprietary mobile line production system, and an considerable capsid and promoter library. With world-wide headquarters in Investigation Triangle Park, North Carolina, and European headquarters in Edinburgh, Uk, the organization has created hundreds of proprietary capsids and promoters, many of which have entered clinical testing. Launched in 2001 and an early innovator in the gene remedy field, the corporation retains much more than 750 patents in locations such as AAV manufacturing and chimeric and self-complementary capsids. Learn much more at www.askbio.com or comply with us on LinkedIn. 

About Bayer

Bayer is a world wide company with main competencies in the life science fields of wellness treatment and diet. Its solutions and providers are built to assistance individuals and the planet thrive by supporting attempts to master the important difficulties presented by a expanding and growing older worldwide inhabitants. Bayer is fully commited to driving sustainable growth and creating a favourable effect with its businesses. At the exact same time, the Team aims to increase its earning electrical power and build price as a result of innovation and expansion. The Bayer manufacturer stands for believe in, reliability, and good quality all through the world. In fiscal 2021, the Team employed all around 100,000 men and women and had product sales of 44.1 billion euros. R&D expenditures ahead of specific products amounted to 5.3 billion euros. For additional information and facts, visit www.bayer.com. 

AskBio Ahead-Seeking Statements

This push launch includes “ahead-looking statements.” Any statements contained in this press release that are not statements of historical reality may perhaps be considered to be forward-hunting statements. Phrases this kind of as “thinks,” “anticipates,” “designs,” “expects,” “will,” “intends,” “probable,” “probable” and comparable expressions are intended to detect ahead-looking statements. These ahead-looking statements involve without having limitation statements regarding AskBio’s pipeline of advancement candidates, production technological innovation and course of action. These forward-on the lookout statements contain hazards and uncertainties, many of which are outside of AskBio’s regulate. Recognized threats consist of, amid other individuals: AskBio could not be equipped to execute on its small business strategies and targets, together with assembly its predicted or planned regulatory milestones and timelines, its reliance on 3rd-parties, clinical improvement ideas, producing processes and designs, and bringing its merchandise candidates to marketplace, due to a variety of explanations, together with the ongoing COVID-19 pandemic, probable limits of corporation financial and other sources, production limits that could not be anticipated or resolved in a timely fashion, potential disagreements or other challenges with our 3rd-bash collaborators and partners, and regulatory, court or agency suggestions or selections, these types of as feed-back and decisions from the United States Food items and Drug Administration or the United States Patent and Trademark Office. Any of the foregoing pitfalls could materially and adversely have an impact on AskBio’s business and final results of operations. You need to not position undue reliance on the forward-on the lookout statements contained in this push launch. AskBio does not undertake any obligation to publicly update its forward-on the lookout statements primarily based on functions or situations after the day hereof. 

View unique information to down load multimedia:https://www.prnewswire.com/information-releases/askbio-ceo-and-co-founder-sheila-mikhail-receives-2022-entrepreneurial-award-from-college-of-chicago-booth-college-of-company-301560981.html

Resource AskBio